Skip to main navigation Skip to search Skip to main content

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease (PLoS ONE (2017) 12:8 (e0179710) DOI: 10.1371/journal.pone.0179710)

  • Amanda D. Williams
  • , Olga Y. Korolkova
  • , Amos M. Sakwe
  • , Timothy M. Geiger
  • , Samuel D. James
  • , Roberta L. Muldoon
  • , Alan Joseph Herline
  • , J. Shawn Goodwin
  • , Michael G. Izban
  • , Mary K. Washington
  • , Duane T. Smoot
  • , Billy R. Ballard
  • , Maria Gazouli
  • , Amosy E. M’Koma

Research output: Contribution to journalComment/debatepeer-review

Abstract

In Fig 6, the “Active Disease” image for WD- 12919 in Fig 6A was incorrectly duplicated in Fig 6C. Please see the correct Fig 6 here.

Original languageEnglish (US)
Article numbere0189551
JournalPloS one
Volume12
Issue number12
DOIs
StatePublished - Dec 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Agricultural and Biological Sciences
  • General

Fingerprint

Dive into the research topics of 'Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease (PLoS ONE (2017) 12:8 (e0179710) DOI: 10.1371/journal.pone.0179710)'. Together they form a unique fingerprint.

Cite this